Glycolaldehyde-modified β-lactoglobulin AGEs are unable to stimulate inflammatory signaling pathways in RAGE-expressing human cell lines

Molecular Nutrition and Food Research

Volumn 55, Issue 2, 2011, Pages 291-299

  Buetler, Timo M ^a,d   Latado, Hélia ^a   Leclerc, Estelle ^b   Weigle, Bernd ^c   Baumeyer, Alexandra ^a,e   Heizmann, Claus W ^d   Scholz, Gabriele ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b NORTH DAKOTA STATE UNIVERSITY   (United States)

^c University of Zürich ^*  (Germany)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e AGROSCOPE LIEBEFELD POSIEUX RESEARCH STATION ALP   (Switzerland)

Author keywords

Advanced glycation endproducts; Endotoxin; Inflammatory cytokines; Receptor for AGE; Triton X 114

Indexed keywords

ACETALDEHYDE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CYTOKINE; DETERGENT; DRUG DERIVATIVE; ENDOTOXIN; GLYCOLALDEHYDE; IMMUNOGLOBULIN RECEPTOR; LACTOGLOBULIN; MACROGOL DERIVATIVE; MESSENGER RNA; NONIDET P-40; TRITON X 114;

ARTICLE; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; GENETICS; HUMAN; INFLAMMATION; ISOLATION AND PURIFICATION; METABOLISM; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

ACETALDEHYDE; CELL LINE; CYTOKINES; DETERGENTS; ENDOTOXINS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; LACTOGLOBULINS; POLYETHYLENE GLYCOLS; RECEPTORS, IMMUNOLOGIC; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 79551571721     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000140     Document Type: Article

References (32)

1. Stern, D., Yan, S. D., Yan, S. F., Schmidt, A. M., Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv. Drug Deliv. Rev. 2002, 54, 1615-1625.
2. Chavakis, T., Bierhaus, A., Nawroth, P. P., RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect. 2004, 6, 1219-1225.
3. Ramasamy, R., Vannucci, S. J., Shi Du Yan, S., Herold, K. et al., Advanced glycation end products & RAGE: a common thread in aging, diabetes, neurodegeneration & inflammation. Glycobiology 2005, 15, 16R-28R.
4. Jandeleit-Dahm, K., Watson, A., Soro-Paavonen, A., The AGE/RAGE axis in diabetes-accelerated atherosclerosis. Clin. Exp. Pharmacol. Physiol. 2008, 35, 329-334.
5. Schmidt, A. M., Yan, S. D., Yan, S. F., Stern, D. M., The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 2001, 108, 949-955.
6. Riehl, A., Nemeth, J., Angel, P., Hess, J., The receptor RAGE: bridging inflammation and cancer. Cell Commun. Signal. 2009, 7, 12.
7. Brett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S. et al., Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 1993, 143, 1699-1712.
8. Heizmann, C. W., Ackermann, G. E., Galichet, A., Pathologies involving the S100 proteins and RAGE. Subcell. Biochem. 2007, 45, 93-138.
9. Leclerc, E., Fritz, G., Vetter, S. W., Heizmann, C. W., Binding of S100 proteins to RAGE: an update. Biochim. Biophys. Acta 2009, 1793, 993-1007.
10. Huttunen, H. J., Rauvala, H., Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J. Intern. Med. 2004, 255, 351-366.
11. Sturchler, E., Galichet, A., Weibel, M., Leclerc, E., Heizmann, C. W., Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity. J. Neurosci. 2008, 28, 5149-5158.
12. Henle, T., Miyata, T., Advanced glycation end products in uremia. Adv. Ren. Replace. Ther. 2003, 10, 321-331.
13. Thornalley, P. J., Battah, S., Ahmed, N., Karachalias, N. et al., Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem. J. 2003, 375, 581-592.
14. Thorpe, S. R., Baynes, J. W., Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 2003, 25, 275-281.
15. Uetz-von Allmen, E., Koch, M., Fritz, G., Legler, D. F., V domain of RAGE interacts with AGEs on prostate carcinoma cells. Prostate 2008, 68, 748-758.
16. Xie, J., Reverdatto, S., Frolov, A., Hoffmann, R. et al., Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J. Biol. Chem. 2008, 283, 27255-27269.
17. Ostendorp, T., Leclerc, E., Galichet, A., Koch, M. et al., Structural and functional insights into RAGE activation by multimeric S100B. EMBO J. 2007, 26, 3868-3878.
18. Valencia, J. V., Weldon, S. C., Quinn, D., Kiers, G. H. et al., Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics. Anal. Biochem. 2004, 324, 68-78.
19. Valencia, J. V., Mone, M., Koehne, C., Rediske, J., Hughes, T. E., Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products. Diabetologia 2004, 47, 844-852.
20. Reznikov, L. L., Waksman, J., Azam, T., Kim, S. H. et al., Effect of advanced glycation end products on endotoxin-induced TNF-alpha, IL-1beta and IL-8 in human peripheral blood mononuclear cells. Clin. Nephrol. 2004, 61, 324-336.
21. Adam, O., Vercellone, A., Paul, F., Monsan, P. F., Puzo, G., A nondegradative route for the removal of endotoxin from exopolysaccharides. Anal. Biochem. 1995, 225, 321-327.
22. Liu, S., Tobias, R., McClure, S., Styba, G. et al., Removal of endotoxin from recombinant protein preparations. Clin. Biochem. 1997, 30, 455-463.
23. Magalhaes, P. O., Lopes, A. M., Mazzola, P. G., Rangel-Yagui, C. et al., Methods of endotoxin removal from biological preparations: a review. J. Pharm. Pharm. Sci. 2007, 10, 388-404.
24. Reichelt, P., Schwarz, C., Donzeau, M., Single step protocol to purify recombinant proteins with low endotoxin contents. Protein Expr. Purif. 2006, 46, 483-488.
25. Bordier, C., Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 1981, 256, 1604-1607.
26. Aida, Y., Pabst, M. J., Removal of endotoxin from protein solutions by phase separation using Triton X-114. J. Immunol. Methods 1990, 132, 191-195.
27. Srikrishna, G., Huttunen, H. J., Johansson, L., Weigle, B. et al., N-Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth. J. Neurochem. 2002, 80, 998-1008.
28. Hegele, J., Buetler, T., Delatour, T., Comparative LC-MS/MS profiling of free and protein-bound early and advanced glycation-induced lysine modifications in dairy products. Anal. Chim. Acta 2008, 617, 85-96.
29. Roden, L. D., Myszka, D. G., Global analysis of a macromolecular interaction measured on BIAcore. Biochem. Biophys. Res. Commun. 1996, 225, 1073-1077.
30. Buetler, T. M., Leclerc, E., Baumeyer, A., Latado, H. et al., N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response. Mol. Nutr. Food Res. 2008, 52, 370-378.
31. Spanneberg, R., Osswald, F., Kolesov, I., Anton, W. et al., Model studies on chemical and textural modifications in gelatin films by reaction with glyoxal and glycolaldehyde. J. Agric. Food Chem. 2010, 58, 3580-3585.
32. Hui, Y. Y., McAmis, W. C., Baynes, J. W., Schaeffer, R. C., Jr., Wolf, M. B., Effect of advanced glycation end products on oxidative stress in endothelial cells in culture: a warning on the use of cells studied in serum-free media. Diabetologia 2001, 44, 1310-1317.